Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

4 Jan 2007 07:00

Tarsus Group PLC04 January 2007 4 January 2007 TARSUS GROUP PLC TRADING UPDATE Tarsus Group PLC ("Tarsus" or "the Group"), the international media group withinterests in exhibitions, conferences, publishing and online media has continuedto trade well in the second half of 2006. Trading for the full year remains inline with Directors' expectations notwithstanding significant US Dollar weaknessin the second half of our financial year. Like-for-like organic revenue growth was a healthy 14%, led by 2 of the Group'slargest events during the year - Labelexpo Americas and Heavent (France) - whichtraded above this overall level. The August Off-Price show once again producedrecord revenues which were slightly ahead of the 2005 result. Generally,attendances at our events in the second half were strong, particularly in Francewhich is benefiting from an improving economic environment. Revenues from emerging markets doubled on a like-for-like basis. We havecontinued to develop our Chinese portfolio throughout 2006 and expect this to bean area of further development in 2007. Caroo - our online business - trebled its revenues, boosted by the acquisitionsof Onrec and TSNN.com. Annualised revenues at Caroo are now running atapproximately £2 million. Elsewhere, Labels and Labelling magazine had anothergood year with revenues up by 10%. Our organic growth strategy has been supplemented by a small number of focusedacquisitions. In October we acquired Proseg, the leading annual facilitiesmanagement exhibition in Paris and then, in November, we announced the purchaseof 80% of Medical Conferences International Inc. (MCII). This was accompanied bya vendor placing of 5.3 million new ordinary shares at 207p, raisingapproximately £10.5 million after expenses. MCII is the leading anti-ageing andregenerative medicine conference and exhibition in the United States with annualevents in Las Vegas, Orlando and Chicago. A number of joint ventures toreplicate the event outside of the United States have been agreed for 2007. TheDecember Las Vegas event produced a strong performance with revenues andattendees up by 55% and 34% respectively, both slightly ahead of ourexpectations at the time of acquisition. Integration is proceeding well. MCII creates a fifth major division to our business and further adds to theorganic growth capability of the Group. Outlook for 2007 The broadening of the Group's base is an important step in underpinning ourability to grow consistently in the years ahead. For 2007, we expect continuedgood levels of organic growth in our portfolio as a result of the increasedlevel of new product development that we have undertaken in the last two years,as well as from the recent acquisitions that we have completed. In 2007, our Labelexpo exhibition returns to Europe and, as a result, we expectour US$ denominated earnings to be nearer 50% of the Group's total earningscompared with approximately 90% in 2006. Forward booking for this - our largestsingle event - are strong. The underlying momentum of the business is positive and we continue to generatestrong cash flows which are being reinvested for further growth. Although we areat a very early stage of the year, the Directors are confident that 2007 will beanother year of strong progress for the Group. Ends For further information please contact: Tarsus Group plc: Douglas Emslie Group Managing Director: Tel 020 8846 2700 Media: Matthew Moth Madano Partnership: Tel: 020 7593 4000 Investors: Neville Harris IRFocus: Tel: 020 7593 4215 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Nov 20087:00 amRNSInterim Management Statement
31st Oct 200812:35 pmRNSResults of Court Meeting and General Meeting
16th Oct 20084:15 pmRNSHolding(s) in Company
8th Oct 20083:38 pmRNSIntroduction of a new UK-listed holding company
26th Sep 20087:00 amRNSAdditional Listing
19th Aug 20082:39 pmRNSHolding(s) in Company
15th Aug 20081:54 pmRNSDirector/PDMR Shareholding
11th Aug 20083:37 pmRNSDirector/PDMR Shareholding
1st Aug 200810:01 amRNSTotal Voting Rights - Replace
31st Jul 20086:22 pmRNSInterim Results - Replacement
31st Jul 20087:00 amRNSInterim Results
31st Jul 20087:00 amRNSTotal Voting Rights
24th Jul 20082:00 pmRNSNotice of Results
16th Jul 20082:57 pmRNSPDMR Shareholding & Additiona
7th Jul 200811:06 amRNSHolding(s) in Company
2nd Jul 200810:43 amRNSHolding(s) in Company
30th Jun 200810:45 amRNSPDMR Shareholding & Additiona
30th Jun 20087:00 amRNSDirectorate Change
30th Jun 20087:00 amRNSTrading Statement
27th Jun 20083:30 pmRNSHolding(s) in Company
24th Jun 20086:26 pmRNSDirector/PDMR Shareholding
2nd Jun 200811:26 amRNSPDMR Shareholding & Additiona
30th May 200810:28 amRNSTotal Voting Rights
16th May 200812:11 pmRNSHolding(s) in Company
16th May 20087:00 amRNSDirector/PDMR Shareholding
24th Apr 20084:06 pmRNSHolding(s) in Company
23rd Apr 20089:41 amRNSAdditional Listing
17th Apr 20083:14 pmRNSAGM Statement
17th Apr 20087:00 amRNSInterim Management Statement
7th Apr 20084:29 pmRNSDirector/PDMR Shareholding
4th Apr 20084:50 pmRNSDirector/PDMR Shareholding
4th Apr 20084:48 pmRNSHolding(s) in Company
1st Apr 20085:33 pmRNSHolding(s) in Company
1st Apr 20084:45 pmRNSHolding(s) in Company
20th Mar 200812:02 pmRNSAnnual Report and Accounts
3rd Mar 20087:00 amRNSAcquisition
3rd Mar 20087:00 amRNSFinal Results
31st Jan 20085:15 pmRNSTotal Voting Rights
31st Jan 20085:12 pmRNSHolding(s) in Company
31st Jan 20085:12 pmRNSHolding(s) in Company
17th Jan 20085:21 pmRNSAdditional Listing
7th Jan 20087:00 amRNSTrading Statement
20th Nov 200710:56 amRNSAdditional Listing
12th Nov 20077:00 amRNSJoint Venture
12th Nov 20077:00 amRNSAcquisition
2nd Nov 200711:56 amRNSAdditional Listing
1st Nov 20073:37 pmRNSTotal Voting Rights
26th Oct 20071:55 pmRNSHolding(s) in Company
23rd Oct 200711:52 amRNSAdditional Listing
23rd Oct 200711:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.